0001437749-17-000152.txt : 20170104 0001437749-17-000152.hdr.sgml : 20170104 20170104161505 ACCESSION NUMBER: 0001437749-17-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001053691 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300645032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: (434) 220-0718 MAIL ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: RestorGenex Corp DATE OF NAME CHANGE: 20140307 FORMER COMPANY: FORMER CONFORMED NAME: Stratus Media Group, Inc DATE OF NAME CHANGE: 20080722 FORMER COMPANY: FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC. DATE OF NAME CHANGE: 20080228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Byrne Thomas E CENTRAL INDEX KEY: 0001663220 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37942 FILM NUMBER: 17505550 MAIL ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER NAME: FORMER CONFORMED NAME: Byrne Thomas S DATE OF NAME CHANGE: 20160108 4 1 rdgdoc.xml FORM 4 X0306 4 2017-01-03 0001053691 Diffusion Pharmaceuticals Inc. DFFN 0001663220 Byrne Thomas E 2020 AVON COURT, SUITE 4 CHARLOTTESVILLE VA 22902 1 General Counsel Stock Option (Right to Buy) 2.26 2017-01-03 4 A 0 4673 0 A 2027-01-03 Common Stock 4673 4673 D The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on December 31, 2019. /s/ Ben Shealy, attorney-in-fact for Thomas Byrne 2017-01-04